Bath & Body Works (NYSE:BBWI) Issues Q1 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.36-0.43 for the period, compared to the consensus estimate of $0.42. Bath & Body Works also updated its FY26 guidance to $3.25-360 EPS.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on BBWI shares. JPMorgan Chase & Co. set a $47.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Raymond James restated an “outperform” rating and set a $46.00 target price (up from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Finally, Piper Sandler lifted their price target on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.06.

Bath & Body Works Trading Down 2.3 %

Shares of BBWI opened at $29.75 on Wednesday. The firm has a market capitalization of $6.44 billion, a P/E ratio of 7.26, a P/E/G ratio of 0.92 and a beta of 1.89. The firm has a fifty day moving average price of $36.91 and a 200-day moving average price of $34.10. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Analysts predict that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were issued a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.69%. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works announced that its board has approved a share buyback plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.